5-Nitro-2,3-pyridinediamine

Catalog No.: 
ACSKXY458
CAS No.: 
3537-14-2
Molecular Formula: 
C5H6N4O2
Molecular Weight: 
154.13
5-Nitro-2,3-pyridinediamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$73.00In stockInquiry
250mg95%$118.00In stockIn stock
1g95%$298.00In stockIn stock
5g95%$880.00In stockIn stock
10g95%$1408.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Nitro-2,3-pyridinediamine
IUPAC Name5-nitropyridine-2,3-diamine
MDL No.MFCD10697697
Molecular FormulaC5H6N4O2
Molecular Weight154.13
SMILESNC1=NC=C([N+]([O-])=O)C=C1N
InChI KeyJOQJNCSAEMIZOU-UHFFFAOYSA-N
Synonym5-Nitro-2,3-pyridinediamine;2,3-DiaMino-5-nitropyridine;NSC 107296;5-NITROPYRIDINE-2,3-DIAMINE;2,3-Pyridinediamine, 5-nitro-;5-NITROPYRIDINE-2,3-DIAMINE ISO 9001:2015 REACH
CAS No.3537-14-2
PubChem CID3480151

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSKXY458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLABI509 route compound structure diagram
    ACLABI5093073-30-1In Stock
  2. Then
  3. ACSKXY458 route product structure diagram
    ACSKXY4583537-14-2In Stock
Inquiry

2. ACSKXY458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACLABI509 route compound structure diagram
    ACLABI5093073-30-1In Stock
  4. Then
  5. ACSKXY458 route product structure diagram
    ACSKXY4583537-14-2In Stock
Inquiry

3. ACSKXY458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSKXY458 route product structure diagram
    ACSKXY4583537-14-2In Stock
Inquiry

Comments (0)